{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:43:25Z","timestamp":1793457805177,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119115","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:07:50Z","timestamp":1782850070000},"page":"119115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and evaluation of dual modulators targeting glutaminyl cyclase and cannabinoid CB2 receptor"],"prefix":"10.1016","volume":"317","author":[{"given":"Ziyao","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhang","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3979-7304","authenticated-orcid":false,"given":"Haiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119115_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2006.06.026","article-title":"Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics","volume":"545","author":"Butterfield","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119115_bib2","article-title":"Alzheimer's disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2026.119115_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1656906","article-title":"Comparative efficacy and safety of symptomatic therapy and disease-modifying therapy for Alzheimer's disease: a systematic review and network meta-analysis","volume":"19","author":"Liu","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119115_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104342","article-title":"Human glutaminyl cyclase: structure, function, inhibitors and involvement in Alzheimer's disease","volume":"147","author":"Vijayan","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119115_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175178","article-title":"Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases","volume":"931","author":"Zhang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119115_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-009-0557-5","article-title":"Intraneuronal pyroglutamate-Abeta 3\u201342 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model","volume":"118","author":"Wirths","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2026.119115_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-016-0380-x","article-title":"pGluA\u03b2 increases accumulation of A\u03b2 in vivo and exacerbates its toxicity","volume":"4","author":"Sofola-Adesakin","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejmech.2026.119115_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/jnc.15114","article-title":"Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals","volume":"156","author":"Gunn","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.119115_bib10","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.3233\/JAD-231126","article-title":"Varoglutamstat: inhibiting glutaminyl cyclase as a novel target of therapy in early alzheimer's disease","volume":"101","author":"Feldman","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119115_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/jpet.117.240614","article-title":"Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of alzheimer's disease\u2014studies on relation to effective target occupancy","volume":"362","author":"Hoffmann","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119115_bib12","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/acs.jmedchem.7b00098","article-title":"Discovery of potent human glutaminyl cyclase inhibitors as anti-alzheimer\u2019s agents based on rational design","volume":"60","author":"Hoang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib13","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1021\/acs.jmedchem.7b00648","article-title":"Synthesis and evaluation of diphenyl conjugated imidazole derivatives as potential glutaminyl cyclase inhibitors for treatment of alzheimer's disease","volume":"60","author":"Li","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113819","article-title":"Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-alzheimer's agents by the combination of pharmacophore-based and structure-based design","volume":"226","author":"Van Manh","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib15","author":"Vivoryon Therapeutics"},{"key":"10.1016\/j.ejmech.2026.119115_bib16","first-page":"259","article-title":"The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders, dialogues clin","volume":"22","author":"Di Marzo","year":"2022","journal-title":"Neurosci"},{"key":"10.1016\/j.ejmech.2026.119115_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107657","article-title":"A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders","volume":"213","author":"Garc\u00eda-Guti\u00e9rrez","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119115_bib18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41419-024-07249-6","article-title":"Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer's disease mice by controlling astrocyte activation","volume":"15","author":"Sobue","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119115_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lfs.2018.11.058","article-title":"Cannabinoid type 2 receptor agonist JWH-133, attenuates okadaic acid induced spatial memory impairment and neurodegeneration in rats","volume":"217","author":"\u00c7ak\u0131r","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.119115_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123000","article-title":"Cannabinoid CB2 receptors in neurodegenerative proteinopathies: new insights and therapeutic potential","volume":"10","author":"Vuic","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.119115_bib21","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119115_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2026.119115_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135207","article-title":"Activation of cannabinoid receptor 2 protects rat hippocampal neurons against A\u03b2-induced neuronal toxicity","volume":"735","author":"Zhao","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2026.119115_bib24","doi-asserted-by":"crossref","first-page":"49773","DOI":"10.1074\/jbc.M309077200","article-title":"Identification of human glutaminyl cyclase as a metalloenzyme","volume":"278","author":"Schilling","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1209863","article-title":"Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2026.119115_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117019","article-title":"Design, synthesis, and evaluation of 4-(4-methyl-4H-1,2,4-triazol-3-yl)piperidine derivatives as potential glutaminyl cyclase isoenzyme inhibitors for the treatment of cancer","volume":"281","author":"Zhou","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib27","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1021\/acs.jmedchem.7b00155","article-title":"Perspectives of cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative disorders: structure\u2013affinity relationship (SAfiR) and structure\u2013activity relationship (SAR) studies","volume":"60","author":"Spinelli","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejmech.2014.11.066","article-title":"Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands","volume":"90","author":"Bertini","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119115_bib29","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.1039\/D6SC00062B","article-title":"Single-position ligand modifications tune CB2R activity by targeting the toggle switch","volume":"17","author":"Ganzoni","year":"2026","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119115_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.intimp.2011.04.013","article-title":"Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor","volume":"11","author":"Zhang","year":"2011","journal-title":"Int. Immunopharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600560X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600560X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:01:50Z","timestamp":1787040110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600560X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"alternative-id":["S022352342600560X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119115","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of dual modulators targeting glutaminyl cyclase and cannabinoid CB2 receptor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119115"}}